GlobeStar Therapeutics Corp
GSTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$124.11K
Close$
$-0.00
500% downside
Current Fair Value
500% downsideOvervalued by 500% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $124,111.00 |
|---|---|
| Enterprise Value | $211,843.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.07 |
| Outstanding Shares | 1,208,972,000 |
Return
| Return on Equity | 54.58% |
|---|---|
| Return on Assets | -1057.49% |
| Return on Invested Capital | 49.09% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.05 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.27 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -0.05 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About GlobeStar Therapeutics Corp
1 employees